The amount of fibrinogen-positive platelets predicts the occurrence of in-stent restenosis

Atherosclerosis

Volumn 197, Issue 1, 2008, Pages 190-196

  Jaster, Markus ^a   Horstkotte, Dieter ^b   Willich, Tobias ^a   Stellbaum, Caroline ^a   Knie, Wulf ^a   Spencker, Sebastian ^a   Pauschinger, Mathias ^a   Schultheiss, Heinz Peter ^a   Rauch, Ursula ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Acute myocardial infarction; Fibrinogen; In stent restenosis; IVUS; Neointima proliferation; Thrombocytes

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CORONARY STENT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; SENSITIVITY AND SPECIFICITY; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; BLOOD PLATELETS; CORONARY RESTENOSIS; FEMALE; FIBRINOGEN; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STENTS; THROMBOSPONDINS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 39449120518     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.03.020     Document Type: Article

References (30)

1. The Stent Primary Angioplasty in Myocardial Infarction Study Group. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 341 (1999) 1949-1956
2. Fernàndez-Ortiz A., Badimon J.J., Falk E., et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 23 (1994) 1562-1569
3. Rauch U., Osende J.I., Fuster V., Badimon J.J., Fayad Z., and Chesebro J.H. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med 134 (2001) 224-238 [Review]
4. Libby P. Molecular bases of the acute coronary syndrome. Circulation 91 (1995) 2844-2850
5. Fuster V., and Lewis A. Conner memorial lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 90 (1994) 2126-2146 [Review]
6. Fuster V., Badimon L., Badimon J.J., and Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (first and second part). NEJM 326 (1992) [242-50 and 310-8. Review]
7. Rogers C., Karnovsky M., and Edelman E. Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. Circulation 88 (1993) 1215-1221
8. Farb A., Sangiorgi G., Carter A.J., et al. Pathology of acute and chronic coronary stenting in humans. Circulation 99 (1999) 44-52
9. Hoffmann R., Mintz G.S., Dussaillant G.R., et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 94 (1996) 1247-1254
10. Painter J.A., Mintz G.S., Wong S.C., et al. Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-schatz stent recoil. Am J Cardiol 75 (1995) 398-400
11. Intracoronary Stenting and Antithrombotic Regimen. Is Abciximab a superior way to eliminate elevated thrombotic risk in Diabeticx (ISAR-SWEET) study investigators. Circulation 110 (2004) 3627-3635
12. Carter A.J., Laird J.R., Farb A., Kufs W., Wortham D.C., and Virmani R. Morphological characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol 24 (1994) 1398-1405
13. Wilentz J.R., Sanborn T.A., Haudenschild C.C., Valeri C.R., Ryan T.J., and Faxon D.P. Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation 75 (1987) 636-642
14. Barry W.L., Gimple L.W., Humphries J.E., et al. Arterial thrombin activity after angioplasty in an atherosclerotic rabbit model: time course and effect of hirudin. Circulation 94 (1996) 88-93
15. Fager G. Thrombin and proliferation of vascular smooth muscle cells. Circ Res 77 (1995) 645-650
16. Clowes A.W., and Clowes M.M. Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration. Circ Res 58 (1986) 839-845
17. Kohno M., Yokokawa K., Yasunari K., et al. Heparin inhibits human coronary artery smooth muscle cell migration. Metabolism 47 (1998) 1065-1069
18. Shin E.K., Son J.W., Sohn M.S., et al. Efficacy of heparin-coated stent in early setting of acute myocardial infarction. Catheter Cardiovasc Interv 52 (2001) 306-312
19. Stone G.W., Brodie B.R., Griffin J.J., et al. Clinical and angiographic follow-up after primary stenting in acute myocardial infarction: the primary angioplasty in myocardial infarction (PAMI) stent pilot trial. Circulation 99 (1999) 1548-1554
20. Reimers B., Di Mario C., Di Francesco L., et al. New approach to quantitative angiographic assessment after stent implantation. Cathet Cardiovasc Diagn 40 (1997) 343-347
21. Uren N.G., Melin J.A., De Bruyne B., Wijns W., Baudhuin T., and Camici R.G. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Eng J Med 330 (1994) 1782-1788
22. Jaster M., Fuster V., Rosenthal P., et al. Catheter based intracoronary brachytherapy leads to increased platelet activation. Heart 90 (2004) 160-164
23. Jaster M., Schwimmbeck P., Spencker S., Schultheiss H.P., and Rauch U. Randomized comparison of platelet-leukocyte aggregates and platelet activation in blood: heparin-coated coiled wire stent implantation versus balloon angioplasty in acute myocardial infarction. Thromb Res 112 (2003) 285-289
24. Mudra H., et al. Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS Study). Circulation 104 (2001) 1343-1349
25. Piorkowski M., Priess J., Weikert U., et al. Abciximab therapy is associated with increased platelet activation and decreased heparin dosage in patients with acute myocardial infarction. Thromb Haemost 94 (2005) 422-426
26. Piorkowski M., Weikert U., Schwimmbeck P., Martus P., Schultheiss H.P., and Rauch U. ADP induced platelet degranulation in healthy individuals is reduced by clopidogrel after pretreatment with atorvastatin. Thromb Haemost 92 (2004) 614-620
27. Schultheiss H.P., Tschoepe D., Esser J., et al. Large platelets continue to circulate in an activated state after myocardial infarction. Eur J Clin Invest 24 (1994) 243-247
28. Schuhlen H., Kastrati A., Mehilli J., et al. Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J 147 (2004) 317-322
29. Cole J., and Weintraub W. Restenosis: are the implications changing?. Am Heart J 147 (2004) 197-199 [Editorial]
30. Ruygrok P.N., Webster M.W., de Valk V., et al. Clinical and angiographic factors associated with asymptomatic restenosis after percutaneous coronary intervention. Circulation 104 (2001) 2289-2294